Non-carbapenemUTIβ-Lactam/β-lactamase inhibitorThis systematic review was conducted to compare the efficacy of non-carbapenem 尾-lactam/尾-lactamase inhibitors (BLBLIs) versus carbapenems for the treatment of urinary tract infections (UTIs) caused by extended-spectrum 尾-lactamase-producing ...
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complica... Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and comp...
K. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci. 1999, 8, 2330-2337.Powers, R. A.; Blazquez, J.; Weston, G. S.; Morosini, M. I.; Baquero, F.; Shoichet, B. K. The complexed structure and antimicrobial ...
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci 1999; 8: 2330-7.Powers, R.A., et al., The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci, 1999. 8(11)...
P. (2018b). Humanized exposures of a β-lactam-β-lactamase inhibitor, tazobactam, versus non-β- lactam-β-lactamase inhibitor, avibactam, with or without colistin, against Acinetobacter baumannii in murine thigh and lung infection models. Pharmacology 101, 255-261. doi: 10.1159/000486445...